Albemarle stock
Price history
−31.54% over the period1 year: from $116.42 (November 20, 2025) to $79.70 (November 20, 2026), −31.54%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $79.70 |
| October 30, 2026 | $91.00 |
| September 30, 2026 | $105.78 |
| August 31, 2026 | $134.97 |
| July 31, 2026 | $117.64 |
| June 30, 2026 | $135.03 |
| May 29, 2026 | $176.42 |
| April 30, 2026 | $196.70 |
| March 31, 2026 | $179.53 |
| February 27, 2026 | $178.67 |
| January 30, 2026 | $170.63 |
| December 31, 2025 | $141.44 |
| November 28, 2025 | $129.99 |
| November 20, 2025 | $116.42 |
At a glance
The company
Provide lithium compounds for energy storage, specialty chemicals including bromine and lithium solutions, and catalysts for clean fuels
Latest results
Quarter to September 30, 2026 · EPS $2.58 (estimate $2.58)
Dividend
TickerLandia's take on Albemarle
- Cheaper than similar companies: trailing 12-month P/E 21 vs 31 (−34%) in a group of 11.
- Strong point: Financial strength (53/100 in its group). Weak point: Earnings stability (4/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−63.94% from the 52-week high
Analysts · 22 analysts
Average target$140.55+76.35% vs. price
Buy 14 · Hold 8 · Sell 0 · Buy
TickerLandia Fingerprint: Albemarle
Compared with similar companies: very low earnings stability and very weak momentum.
Financials and price compared with 59 companies in the specialty chemicals industry, worldwide. Momentum and risk compared with 888 North American stocks.
Pricelow33
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 11.2 18 Price/sales 1.65 55 P/E (trailing 12 months) 20.7 42 EV/EBITDA 7.54 22 Price/book 1.22 27 Profitabilityaverage50
How much it earns on revenue and capital.
Metric Value Position in group ROA 4.0% 35 Gross margin 26.2% 35 Operating margin 17.1% 77 Net margin 11.1% 72 ROE 7.0% 33 Earnings stabilityvery low4
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 26.4% 1 Loss-making yearscounts in reverse: lower means more earnings stability 2 of 5 annual reports 8 Growthlow31
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +18.80% 77 Earnings growth (year over year) −225.00% 3 Average revenue growth (3 years) −11.10% 14 Financial strengthaverage53
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 0.40 6 Debt/equitycounts in reverse: lower means more financial strength 0.18 91 Current ratio 2.34 81 Net debt/EBITDAcounts in reverse: lower means more financial strength 2.31 35 Dividendaverage52
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 1.9% 44 Payout ratio 39.2% 32 Consecutive dividend years at least 33 years 81 Market momentumvery weak4
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −34.33% 5 Relative strength (6 months) −49.63% 2 1-year return −31.54% 8 Distance from 200-day average −44.51% 2 Riskhigh75
How much the price swings.
Metric Value Position in group Beta (1 year) 1.15 69 Volatility (60 days) 40.4% 62 Maximum drawdown (12 months) 63.0% 95
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Albemarle is cheaper than similar companies
Albemarle's P/E (trailing 12 months): 20.7, −34% against the median of a group of 11 similar companies (31.3).
Compared with 11 similar companies
| Metric | Albemarle | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 20.7 | Middle | |
| Forward P/E | 11.2 | Low | |
| Operating margin | 17.1% | Middle | |
| ROE | 7.0% | Middle | |
| Debt/equity | 0.18 | Low |
Grey band: the middle half of the group; tick: the median; dot: Albemarle. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.55B
Latest quarter · Q3 2026
Net income
$296.76M
Latest quarter · Q3 2026
Quarterly net margin
19.1%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $10.13B
- P/E
- 20.7
- EPS
- $4.15
- Volume
- 2.16M
- Daily trading
- €214.08M
- Dividend yield
- 2.04%
How Albemarle is changing
All resultsRevenue grew 10.4% a year on average over the last 5 years
Operating margin fell from 33.7% to −7.1%
Shares outstanding up 10.2% in 5 years
Returns
Albemarle returns with dividends
$1,000 invested in Albemarle 5 years ago, on November 22, 2021, would be worth $299 today with dividends reinvested: −70.14% in total, −21.49% per year. On price alone it would be $281 (−71.92%).
| Period | Albemarle | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | −16.78% | −10.40% | $832 |
| 6 months | −53.18% | −7.03% | $468 |
| Year to date | −43.65% | +0.95% | $563 |
| 1 year | −30.75% | +5.68% | $692 |
| 3 years | −35.89% | +51.96% | $641 |
| 5 years | −70.14% | +47.57% | $299 |
| 10 years | +8.67% | +214.37% | $1,087 |
Over the last 6 months it has done better than 3% of the stocks in the Materials sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Albemarle: technical analysis
Albemarle is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 75.5% below its all-time closing high ($325.38, November 11, 2022).
- Trend
- Downward
- RSI (14 sessions)
- 25
- Below 30: a strong fall in a short time
- vs 200-session average
- −44.51%
Active signals
New 52-week low.
since November 16, 2026
Close below the low of the previous 55 sessions.
since November 16, 2026
RSI below 30: the stock has fallen a lot in a short time.
since November 19, 2026
Support and resistance
Price areas where Albemarle has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$131.95+65.56%2 touches, last on August 26, 2026
- Resistance$117.60+47.55%2 touches, last on September 22, 2026
- Resistance$90.38+13.41%2 touches, last on October 30, 2026
- Last price$79.70
- No support below: the price is near the lows of the year
Volatility and risk
Over the last year it has moved roughly in line with the S&P 500.
- Beta (1 year) vs S&P 500
- 1.15
- Volatility (60 sessions, annualised)
- 40.4%
- Largest fall in the last year
- −63.04%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Albemarle: seasonality
Average monthly price change over 33 years
Over the last 33 years, the strongest month for Albemarle has been November: +5.03% on average, positive in 22 years out of 32. The weakest has been June: −2.71% on average, positive in 15 years out of 33.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.29% | −1.55% | 13 of 32 |
| February | +1.55% | +3.09% | 21 of 32 |
| March | +0.53% | −0.57% | 16 of 33 |
| April | +2.72% | +3.10% | 24 of 33 |
| May | +3.41% | +1.90% | 20 of 33 |
| June | −2.71% | −1.75% | 15 of 33 |
| July | +1.56% | −0.14% | 15 of 33 |
| August | +0.05% | +0.60% | 20 of 33 |
| September | −0.63% | −1.04% | 16 of 33 |
| October | +2.16% | +2.17% | 19 of 33 |
| November | +5.03% | +4.97% | 22 of 32 |
| December | +0.94% | +2.87% | 18 of 32 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Albemarle and its competitors
Albemarle's lithium compounds, such as lithium carbonate and lithium hydroxide, go into batteries for electric vehicles and consumer electronics. The company also sells bromine-based specialty chemicals, fire safety compounds and butyllithium, while its Ketjen unit supplies hydroprocessing and catalytic cracking catalysts for clean fuels production. Its customers include automotive, aerospace and electronics makers as well as pharmaceutical and medical device companies, and it serves grid storage, construction and agriculture markets.
- Headquarters
- Charlotte, United States
- Employees
- 7,800
- Founded
- 1994
- Chief executive
- Jerry Masters
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| AlbemarleALB | $10.13B | 17.1% | 20.7 | −53.18% |
| RPM InternationalRPM | $13.08B | 12.8% | 19.0 | +4.09% |
| Eastman ChemicalEMN | $6.72B | 10.7% | 10.5 | −16.82% |
| Lyondellbasell IndustriesLYB | $18.05B | 9.2% | 13.5 | −21.68% |
| Dupont De NemoursDD | $19.27B | 14.4% | 50.7 | +2.60% |
| International Flavors & FragrancesIFF | $19.94B | 8.1% | 227.5 | +6.97% |
Same industry or related industries, similar size. Compare Albemarle with its competitors · Full profile
